BioLife Solutions Inc
NASDAQ:BLFS
BioLife Solutions Inc
NASDAQ:BLFS
Price:
18.01 USD
0.39%
Market Closed
Updated:
May 10, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-18.5
Current
-18.7
Median
12.6
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-18.5
Enterprise Value
/
797.5m
EBITDA
-43m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
813.5m USD | -18.5 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.3T JPY | 23 | |
| CH |
|
Alcon AG
SIX:ALC
|
36.3B CHF | 18.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
190B DKK | 25.7 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.1B USD | 25.1 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 23.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.7T KRW | -118.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
60.4B CNY | 32 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 46.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 11.7 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 15.4 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
-1 918.8
2-Years Forward
EV/EBITDA
49.2
3-Years Forward
EV/EBITDA
21.9
You don't have any saved screeners yet
